Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of resminostat plus docetaxel in advanced non-small cell lung cancer
jRCT2080222077Phase 2
- Sponsor
- Yakult Honsha
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Resminostat in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Yakult Honsha.
02
Drugs
Resminostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT2080222077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222077.